You may think that Canadian and Indian pharmaceutical policy share little in common particularly with respect to what influences policymaking in each country. Think again! Both countries are under considerable pressure from the EU to include highly restrictive data exclusivity arrangements in its policy framework. The implications it has for medicine access is profound especially for low and middle-income countries. ping.fm/01ipH
Best regards, Joao
If you enjoyed this article, please consider sharing it!
